Dr. J AI Secures Strategic Investment from Japan’s Sojitz Corporation
A New Chapter in Global AI-Driven Healthcare Begins
In an era marked by global economic uncertainty, a piece of exciting news has swept across the AI medical landscape in China: Dr. J, a pioneer in AI-powered healthcare innovation, has officially formed a strategic partnership with Sojitz Corporation, a Fortune Global 500 company headquartered in Tokyo, Japan.
Guangzhou Shangyi Internet Information Technology Co., Ltd. (hereafter referred to as Shangyi Cloud) has announced the completion of its Pre-A funding round and a global strategic cooperation agreement with Sojitz. This international collaboration marks a major milestone in Dr. J’s growth and a pivotal step in reshaping the global AI healthcare ecosystem.
Dr. J: Empowering Early Detection of Breast Cancer with AI for Public Health Benefit
Developed independently by Shangyi Cloud’s AI R&D team, the “Dr. J AI Breast Cancer Screening Robot” stands as a breakthrough innovation in China’s AI-driven early disease detection field. Centered on “AI + Ultrasound”, it aims to address critical pain points such as the shortage of primary care resources, low screening coverage, and inconsistent diagnostic standards.
Dr. J has already achieved large-scale real-world deployment across China, with proven success in full-regional AI breast cancer screening programs. The solution has earned recognition and commendation from China’s National Health Commission and the Patriotic Health Campaign Committee.
Key Achievements:
- Established China’s first hands-on AI breast cancer screening training center
- Built one of the world’s largest breast ultrasound image databases
- Partnered with People’s Daily on strategic health initiatives
- Selected in Guangzhou Science & Technology Bureau’s 2024 AI Innovation List
- Named in Top 10 AI+Healthcare Use Cases
- Recognized as a “Lighthouse Project” by Intel, AWS, and NVIDIA
These accolades highlight Dr. J’s leading position in both technological innovation and industrial application.
Sojitz Corporation: A Century-Old Global Giant Empowering AI Healthcare
Founded over a century ago, Sojitz Corporation is a Fortune 500 integrated trading company with operations in 78 countries and more than 20,000 employees worldwide. Guided by its core mission — “Creating value and connecting the world with integrity” — Sojitz has increased its focus on the healthcare sector in recent years, particularly in AI medical innovation and digital transformation.
This strategic investment in Dr. J marks a key move in Sojitz’s global AI healthcare strategy. Leveraging its mature healthcare networks across Southeast Asia, the Middle East, and beyond, Sojitz will actively support Dr. J’s international expansion, bringing advanced AI-driven early screening to women around the world.
This partnership reflects Sojitz’s strong confidence in Dr. J’s technological strength and market potential, and reaffirms both companies’ shared commitment to making quality healthcare accessible globally.
AI-Powered Breast Cancer Screening: Dr. J Safeguards Women’s Health
As of 2020, breast cancer has become the most common malignant tumor globally. According to The Lancet (2023), 40% of Chinese women suffer from breast-related diseases, with 420,000 new breast cancer cases annually, many affecting younger populations. Yet, early diagnosis rates remain under 30%.
Dr. J was created to tackle this public health crisis using cutting-edge AI.
Powered by the LVM4U (Large Vision Model for Ultrasound) — a proprietary AI ultrasound imaging model — Dr. J can automatically:
- Detect lesions
- Determine benign/malignant and cystic/solid properties
- Perform BI-RADS classification
In clinical validation led by the National Cancer Center of China, Dr. J’s diagnostic accuracy rivals that of senior ultrasound doctors. More importantly, with minimal training, general healthcare workers can use the system, significantly expanding screening efficiency and accessibility.
Dr. J also extends its impact beyond hospitals — into community health, mobile clinics, and even the beauty & wellness industry. The solution offers AI-driven breast health evaluations, anti-aging, breast care, and shape-enhancement services, forming a one-stop intelligent ecosystem for women’s breast health across their entire lifecycle.
This fusion of AI + Wellness opens a new growth frontier for the beauty industry.
Looking Ahead: Building a New Global Model for Accessible Healthcare
This strategic collaboration with Sojitz marks the beginning of Dr. J’s international journey and injects powerful momentum into China’s AI healthcare exports.
Moving forward, both parties will co-develop an end-to-end global AI healthcare ecosystem — enabling more equitable access to quality medical services and improving public health worldwide through technological innovation.
Dr. J remains committed to its mission:
“To benefit humanity through AI-powered health technologies.”
By continuously pushing the boundaries of innovation, Dr. J aims to deliver more intelligent healthcare solutions to households across the globe, contributing Chinese wisdom and solutions to the future of global health.
We empower those healing the world.
